Clinical Trials Browser

Phase 3 × Radium-223 × 30 days × Clear all

NCT03574571 2026-02-27

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

Phase 3 Active not recruiting

Prostatic Neoplasms